Insider · CIK 0002050276
Robert Sturrus
officer
Files at ALIT (Alight, Inc. / Delaware). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -3,409 | $1.59 | $5,420 | 264,818 | Jan 20, 2026 |
| Mar 11, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -1,607 | $6.03 | $9,690 | 268,227 | Mar 13, 2025 |
| Mar 10, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -3,459 | $6.16 | $21k | 229,250 | Mar 12, 2025 |
| Mar 10, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +40,584 | $0.00 | $0 | 269,834 | Mar 12, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +179,376 | $0.00 | $0 | 250,229 | Mar 4, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -17,520 | $6.83 | $120k | 232,709 | Mar 4, 2025 |
| Feb 12, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +20,583 | $0.00 | $0 | 77,975 | Feb 14, 2025 |
| Feb 12, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -7,122 | $6.64 | $47k | 70,853 | Feb 14, 2025 |
| Jan 15, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +20,618 | $0.00 | $0 | 57,392 | Jan 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.